As a biotech beauty brand, we use innovative technology to create the best, most effective, and sustainable ingredients
USADA i WADA nie zakazay stosowania BPC 157
Kim SY, Yang CS, Lee HM, Kim JK, Kim YS, Kim YR, Kim JS, Kim TS, Yuk JM, Dufour CR, et al
But important limitations exist: Most research is in animals, not humans Long-term safety beyond 12 weeks is uncharacterized Drug interactions haven't been formally studied Cancer relationship remains unclear Who should consider BPC-157: Those researching recovery support for injuries or gut issues Individuals willing to accept calculated risk with an experimental peptide People who can work with a knowledgeable healthcare provider Who should avoid it: Those with active cancer or high cancer risk Anyone on medications that might interact (especially cardiovascular, dopamine-affecting) Individuals unwilling to monitor their response carefully If you choose to use BPC-157, start conservatively (200 mcg daily), use proper injection technique, source from reputable suppliers, and track your body's response

Kleinman, of the Department of Biochemistry and Molecular Medicine at The George Washington University School of Medicine and Health Sciences (see the TB-500 component PDP for the Goldstein scientific-author entry)
Potential Cancer Prevention Properties Several studies, primarily in animal models, have examined epithalon for cancer prevention